Theriva Biologics, Inc. (TOVX) (CIK 0000894158) CORRESP

Theriva Biologics, Inc. (TOVX) (CIK 0000894158) → SEC staff · filed 2025-12-01 · ticker TOVX · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001104659-25-117211
Form
CORRESP
Filer
Theriva Biologics, Inc. (TOVX) (CIK 0000894158)
CIK
0000894158
Ticker
TOVX
Filed
2025-12-01
SIC industry
2834
HQ
Rockville, MD

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/894158/000110465925117211/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗